Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
Br J Cancer
; 130(6): 961-969, 2024 Apr.
Article
in En
| MEDLINE
| ID: mdl-38272963
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Kidney Neoplasms
Type of study:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Br J Cancer
Year:
2024
Document type:
Article
Affiliation country:
Francia
Country of publication:
Reino Unido